Meiragtx, Llc

This study tests a gene therapy (AAV2-hAQP1) injected into the saliva glands to see if it can safely increase saliva production in people with long-term dry mouth after radiation for head and neck cancer. About 276 adults who completed radiation at least 3 years ago will receive …

This study follows adults who previously received a gene therapy (AAV2-hAQP1) for dry mouth caused by radiation treatment for head and neck cancers. Researchers will check for side effects and how well the therapy works over time. About 276 people who already got the therapy in a…

This study tests a gene therapy designed to help people with dry mouth after radiation for head and neck cancer. The treatment delivers a gene into one saliva gland to help it produce more saliva. The trial includes 17 adults and focuses on safety, with follow-up over three years…

This study follows people who received an experimental gene therapy, AAV2hAQP1, for chronic dry mouth caused by past radiation treatment for cancer. Researchers are checking whether the therapy remains safe and whether any improvement in saliva production lasts over time. The goa…